In vitro calcium oxalate crystallisation methods

Urological Research

Volumn 34, Issue 2, 2006, Pages 139-145

  Kavanagh, John P ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

Author keywords

Calcium oxalate; Constant composition; Continuous crystalliser; Crystallisation

Indexed keywords

CALCIUM OXALATE;

CONFERENCE PAPER; CRYSTALLIZATION; HUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; REVERSE OSMOSIS; STEADY STATE; UROLITHIASIS;

CALCIUM OXALATE; CRYSTALLIZATION; MODELS, BIOLOGICAL;

EID: 33645238248     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00240-005-0027-z     Document Type: Conference Paper

References (56)

1. Hess B, Ryall RL, Kavanagh JP, Khan SR, Kok D-J, Rodgers AL, Tiselius HG (2001) Methods for measuring crystallization in urolithiasis research - why, how and when? Eur Urol 40:220
2. Kavanagh JP (1992) Methods for the study of calcium oxalate crystallisation and their application to urolithiasis research. Scan Microsc 6:685
3. Kavanagh JP (1995) Calcium oxalate crystallization in vitro. In: Khan SR (ed) Calcium oxalate in biological systems. CRC press, Boca-Raton, pp 1-21
4. Baumann JM, Affolter B, Brenneisen J, Siegrist HP (1997) Measurement of metastability, growth and aggregation of calcium oxalate in native urine. A new approach for clinical and experimental stone research. Urol Int 59:214
5. Baumann JM, Affolter B, Caprez U, Lauper D, Maier F, Siegrist HP, Zysset T (2000) Nucleation and aggregation of calcium oxalate in whole urine; spectrophotometric sedimentation analysis:a new approach to study the aggregation of calcium oxalate dihydrate. Urol Res 28:147
6. Kavanagh JP, Jones L Rao PN (2000) Calcium oxalate crystallization kinetics studied by oxalate induced turbidity in fresh human urine and artificial urine. Clin Sci 98:151
7. Laube N, Schneider A, Hesse A (2000) A new approach to calculate the risk of calcium oxalate crystallization from unprepared native urine. Urol Res 28:274
8. Laube N, Hergarten S, Hoppe B, Schmidt M, Hesse A (2004) Determination of the calcium oxalate crystallization risk from urine samples: the BONN Risk Index in comparison to other risk formulas. J Urol 172:355
9. Hess B, Nagakawa Y, Coe FL (1989) Inhibition of calcium oxalate monohydrate crystal aggregation by urine proteins. Am J Physiol 233:F455
10. Walton RC, Kavanagh JP, Heywood BR, Rao PN (2005) Calcium oxalates grown in human urine under different batch conditions. J Cryst Growth 284:517
11. Will EJ, Bijvoet OLM, Blomen LJMJ, Van Der Linden H (1983) Growth kinetics of calcium oxalate monohydrate. I. Method and validation. J Cryst Growth 64:297
12. Blomen LJMJ, Will EJ, Bijvoet OLM, Van Der Linden H (1983) Growth kinetics of calcium oxalate monohydrate. I. The variation of seed concentration. J Cryst Growth 64:306
13. Bijvoet OLM, Blomen LJMJ, Will EJ, Van Der Linden H (1983) Growth kinetics of calcium oxalate monohydrate. II. Variation of solution composition. J Cryst Growth 64:316
14. Bramley AS, Hounslow MJ, Ryall RL (1996) Aggregation during precipitation from solution: a method for extracting rates from experimental data. J Colloid Interface Sci 183:155
15. Letellier SR, Lochhead MJ, Campbell AA, Vogel V (1998) Oriented growth of calcium oxalate monohydrate crystals beneath phospholipid monolayers. Biochim Boiphys Acta Generals Subjects 1380:31
16. Whipps S, Khan SR, O'Palko FJ, Backov R, Talham DR (1998) Growth of calcium oxalate monohydrate at phospholipid Langmuir monolayers. J Cryst Growth 192:243
17. Bacov R, Lee CM, Khan SR, Mingotaud C, Fanucci GE, Talham DR (2000) Calcium oxalate monohydrate precipitation at phosphatidylglycerol Langmuir monolayers. Langmuir 16:6013
18. Ouyang JM, Deng SP (2003) Controlled and uncontrolled crystallization of calcium oxalate monohydrate in the presence of citric acid. Dalton Trans, p 2846
19. Shen YH, Yue WJ, Xie AJ, Lin ZQ, Huang FZ (2004) Influence of HSA on the properties of OA/OAM monolayers and the growth of calcium oxalate. Colloids Surface A 234:35
20. Ouyang HM, Deng SP, Zhong JP, Tieke B, Yu SH (2004) Crystallization of calcium oxalate monohydrate at dipalmitoylphosphatidylcholine monolayers in the presence of chondroitin sulfate A. J Cryst Growth 270:646
21. Ouyang JM, Deng SP (2005) Crystallization of calcium oxalate beneath Langmuir monolayers in the presence of urinary inhibitors. Colloids Surface A 257-258:395
22. Azoury R, Garside J, Robertson WG (1986) Calcium oxalate precipitation in a flow system: an attempt to simulate the early stages of stone formation. J Urol 136:150
23. Azoury R, Garside J, Robertson WG (1986) Habit modifiers of calcium oxalate crystals precipitated in a reverse osmosis system. J Cryst Growth 76:259
24. Azoury R, Garside J, Robertson WG (1986) Crystallisation processes using reverse osmosis. J Cryst Growth 79:654
25. Hallson PC, Rose GA (1978) A new urinary test for stone "activity". Br J Urol 50:442
26. Rodgers AL, Wandt MAE (1991) Influence of ageing, pH and various additives on crystal formation in artificial urine. Scan Microsc 5:697
27. Gohel MD, Shum DKY, Li MK (1993) The dual effect of urinary macromolecules on the crystallization of calcium oxalate endogenous in urine. Urol Res 20:13
28. Hojgaard I, Fornander AM, Nilsson MA, Tiselius HG (1996) Crystallization during volume reduction of solutions with an ion-composition corresponding to that in the distal tubuli. Scan Microsc 10:487
29. Hojgaard I, Fornander AM, Nilsson MA, Tiselius HG (1998) The influence of hydroxyapatite seed on the crystallization induced by volume reduction of solutions with an ion composition corresponding to that in the distal tubule at different pH levels. Scand J Urol Nephrol 32:311
30. Hojgaard I, Fornander AM, Nilsson MA, Tiselius HG (1999) Crystallization during volume reduction of solutions with a composition corresponding to that in the collecting duct: the influence of hydroxyapatite seed crystals and urinary macromolecules. Urol Res 27:417
31. Hojgaard I, Fornander AM, Nilsson MA, Tiselius HG (1999) The effect of pH changes on the crystallization of calcium salts in solutions with an ion composition corresponding to that in the distal tubule. Urol Res 27:409
32. Tiselius HG, Hallin A, Lindback B (2001) Crystallisation properties in stone forming and normal subjects' urine diluted using a standardised procedure to match the composition of urine in the distal part of the distal tubule and the middle part of the collecting duct. Urol Res 29:75
33. Fasano JM, Khan SR (2001) Intratubular crystallization of calcium oxalate in the presence of membrane vesicles: an in vitro study. Kidney Int 59:169
34. Peters F, Epple M (2001) Crystallisation of calcium phosphates under constant composition conditions with a double diffusion set-up. Dalton Trans, p 3585
35. Tomson MB, Nancollas GH (1978) Mineralization kinetics: a constant composition approach. Science 200:1059
36. Sheehan ME, Nancollas GH (1980) Calcium oxalate crystal growth - a new constant composition method for modeling urinary stone formation. Invest Urol 17:446
37. Sheehan ME, Nancollas GH (1984) The kinetics of crystallization of calcium oxalate trihydrate. J Urol 132:158
38. Worcester EM, Blumenthal SS, Beshensky AM, Lewand DL (1992) The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Min Res 7:1029
39. Wu WJ, Nancollas GH (1999) Determination of interfacial tension from crystallization and dissolution data: a comparison with other methods. Adv Colloid Interface Sci 79:229
40. Khan SR, Whalen PO, Glenton PA (1993) Heterogeneous nucleation of calcium-oxalate crystals in the presence of membrane-vesicles. J Cryst Growth 134:211
41. Nancollas GH, Wu WJ (2000) Biomineralization mechanisms: a kinetics and interfacial energy approach. J Cryst Growth 211:137
42. Finlayson B. (1972) The concept of a continuous crystalliser. Its theory and application to in vivo and in vitro urinary tract models. Invest Urol 9:258
43. Falope GO, Jones AG, Zauner R (2001) On modelling continuous agglomerative crystal precipitation via Monte Carlo simulation. Chem Eng Sci 56:2567
44. Miller JD, Randolph AD, Drach GW (1977) Observations upon calcium oxalate crystallization in simulated urine. J Urol 117:342
45. Drach GW, Thorson S, Randolph A (1980) Effects of urinary organic macromolecules on crystallization of calcium oxalate: enhancement of nucleation. J Urol 123:519
46. Robertson WG, Scurr DS (1986) Modifiers of calcium oxalate crystallization found in urine. I. Studies with a continuous crystalliser using an artificial urine. J Urol 135:1322
47. Kohri K, Garside J, Blacklock NJ (1989) The effect of glycosaminoglycans on the crystallisation of calcium oxalate. Br J Urol 63:584
48. Nishio S, Kavanagh JP, Faragher EB, Garside J, Blacklock NJ (1990) Calcium oxalate crystallisation kinetics and the effects of calcium and gamma-carboxyglutamic acid. Br J Urol 66:351
49. Nishio S, Kavanagh JP, Garside J (1991) A small scale continuous mixed suspension mixed product removal crystallizer. Chem Eng Si 46:709
50. Kavanagh JP, Nishio S, Garside J, Blacklock NJ (1993) Crystallization kinetics of calcium oxalate in fresh minimally diluted urine: comparison of recurrent stone formers and healthy controls in a continuous mixed suspension mixed product removal crystallizer. J Urol 149:614
51. Kavanagh JP, Jones CL, Rao PN (1999) Calcium oxalate crystallization kinetics at different concentrations of human and artificial urine, with a constant calcium to oxalate ratio. Urol Res 27:231
52. Suzuki K, Tsugawa R, Ryall RL (1991) Inhibition by sodium potassium citrate (CG-120) of calcium oxalate crystal growth on to kidney stone fragments obtained from extracorpopreal shockwave lithotripsy. Br J Urol 68:132
53. Ananth K, Kavanagh JP, Walton RC, Rao PN (2002) Enlargement of calcium oxalate stones to clinically significant size in an in-vitro stone generator. BJU Int 90:939
54. Chow K, Dixon J, Gilpin S, Kavanagh JP, Rao PN (2004) A stone farm: development of a method for simultaneous production of multiple calcium oxalate stones in vitro. Urol Res 32:55
55. Chow K, Dixon J, Gilpin S, Kavanagh JP, Rao PN (2004) Citrate inhibits growth of residual fragments in an in vitro model of calcium oxalate renal stones. Kidney Int 65:1724
56. Grover PK, Moritz RL, Simpson RJ, Ryall RL (1998) Inhibition of growth and aggregation of calcium oxalate crystals in vitro - a comparison of four human proteins. Eur J Biochem 253:637